Seetha Mahalaxmi Healthcare’s Hanooman is slated for launch on May 1, 2024
Generative artificial intelligence (AI) platform Hanooman on April 4 announced a 50-50 percent partnership agreement with Abu Dhabi-based 3AI Holding. Seetha Mahalaxmi Healthcare (SML) introduced Hanooman in February, which is slated for launch on May 1, 2024.
3AI Holding’s Omega generative AI will make Hanooman “bigger and more powerful,” a press release by SML said.
Hanooman aims to reach 200 million users in 22 Indian languages within the first year. The Gen AI platform will offer its multimodal and multilingual capabilities, including text, voice, image, and code to users.
Hanooman, a foundational model built in India, will create a generative AI ecosystem to enable budding generative AI platforms to build their applications. It will also offer the platform to startups and incubate them along with NASSCOM.
With its multilingual capabilities and collaboration with NASSCOM, Hanooman aims to benefit both, end users and corporations.
“3AI Holding’s proprietary, patent-pending Omega generative AI will further help us expand our reach to the masses in a way that has never been possible before,” Vishnu Vardhan, cofounder & CEO, SML India, was quoted as saying in the release.